디지털 의약품 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global digital medicines market size is expected to reach USD 1452.77 Million in 2034 from USD 367.79 Million in 2025, growing at a CAGR of 16.49% during 2026-2034.This market is emerging as healthcare increasingly explores digital technologies that can support medication use, patient monitoring, and treatment management. Digital medicines may include connected drug delivery systems, sensor-enabled medication technologies, and digital platforms that collect information related to medication administration or patient responses. These solutions can help healthcare professionals and patients obtain additional information about treatment adherence and care routines. Growing interest in remote healthcare, personalized treatment, and connected medical devices is encouraging development in this field. The category is evolving, and its scope can vary depending on whether products combine pharmaceuticals with digital monitoring or delivery technologies.

Market growth is driven by healthcare digitalization, advances in wearable sensors, and increasing demand for more informed medication management. Pharmaceutical companies, medical device manufacturers, and digital health developers are exploring technologies that connect medication-related information with mobile applications and clinical platforms. Digital monitoring tools may help identify missed doses or support follow-up for selected treatments. Improvements in wireless communication, secure data transmission, and patient-facing interfaces are helping make connected solutions more practical. In addition, growing interest in value-based healthcare is encouraging providers to investigate tools that may improve adherence monitoring and support continuity of care.

The future prospects of this market will depend on clinical evidence, regulatory clarity, patient acceptance, and integration with healthcare systems. Advances in sensor technology and digital analytics could support more personalized monitoring and improve the usability of connected medication solutions. Interoperability with electronic health records and remote patient monitoring platforms may help healthcare professionals incorporate relevant data into care decisions. However, privacy concerns, cybersecurity risks, device costs, data reliability, and questions about patient consent remain important challenges. Clear clinical benefits and appropriate safeguards will be essential for expanding the use of digital medicines across different therapeutic areas.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Technology

• Mobile Health
• Telehealth
• Wireless Health
• EMR/HER

By Application

• Diabetes
• Asthma
• Heart Disease
• Obesity
• COPD
• Smoking
• Drug Non Adherence
• Mental Health
• Others

COMPANIES PROFILED

• Pear Therapeutics, Click Therapeutics, Akili Interactive, Otsuka Pharmaceutical, MedRhythms, Welldoc, Biofourmis, DarioHealth, Happify Health, Voluntis, Kaia Health, Big Health, Better Therapeutics, Sidekick Health, Swing Therapeutics, Freespira, Orexo, Mahana Therapeutics, Limbix Health, BehaVR

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DIGITAL MEDICINES MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Mobile Health Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Telehealth Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Wireless Health Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. EMR/HER Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DIGITAL MEDICINES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Asthma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Heart Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Obesity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. COPD Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Smoking Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Drug Non Adherence Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Mental Health Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DIGITAL MEDICINES MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Technology
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Technology
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Spain
  • 6.3.8 Russia
  • 6.3.9 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Technology
  • 6.4.2 By Application
  • 6.4.3 China
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 India
  • 6.4.7 Australia
  • 6.4.8 South East Asia
  • 6.4.9 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Technology
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Technology
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL DIGITAL MEDICINES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Pear Therapeutics
  • 8.2.2 Click Therapeutics
  • 8.2.3 Akili Interactive
  • 8.2.4 Otsuka Pharmaceutical
  • 8.2.5 MedRhythms
  • 8.2.6 Welldoc
  • 8.2.7 Biofourmis
  • 8.2.8 DarioHealth
  • 8.2.9 Happify Health
  • 8.2.10 Voluntis
  • 8.2.11 Kaia Health
  • 8.2.12 Big Health
  • 8.2.13 Better Therapeutics
  • 8.2.14 Sidekick Health
  • 8.2.15 Swing Therapeutics
  • 8.2.16 Freespira
  • 8.2.17 Orexo
  • 8.2.18 Mahana Therapeutics
  • 8.2.19 Limbix Health
  • 8.2.20 BehaVR